Henry Schein Inc
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers. A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.7 billion in 2024 and have grown at a compound annual rate of approximately 11.2 percent since Henry Schein became a public company in 1995.
Carries 22.0x more debt than cash on its balance sheet.
Current Price
$78.22
+0.14%GoodMoat Value
$235.74
201.4% undervaluedHenry Schein Inc (HSIC) Financial Statements
GoodMoat Analysis
Henry Schein's financial profile presents a mixed picture for a value investor. The company generates a healthy free cash flow yield and maintains adequate profitability, but its low profit margins, high debt load, and modest growth rate are significant quality concerns.
Read full analysis
HSIC Computed Insights
Income Statement
Balance Sheet
Cash Flow Statement
HSIC Financial Statements & Data
Henry Schein Inc (HSIC) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Henry Schein Inc's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $13.18B. Gross profit (TTM) is $4.11B. EBITDA is $985.00M. Earnings per share (EPS) is $3.27. The P/E ratio is 23.14. Market capitalization is $9.21B.
Free cash flow (FCF) is $521.00M. FCF growth rate is -1.71%. EPS growth CAGR is -8.87%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Henry Schein Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.